These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32350552)

  • 81. Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.
    Roberts TC; Johansson HJ; McClorey G; Godfrey C; Blomberg KE; Coursindel T; Gait MJ; Smith CI; Lehtiö J; El Andaloussi S; Wood MJ
    Hum Mol Genet; 2015 Dec; 24(23):6756-68. PubMed ID: 26385637
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
    Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
    PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene.
    Taglia A; Petillo R; D'Ambrosio P; Picillo E; Torella A; Orsini C; Ergoli M; Scutifero M; Passamano L; Palladino A; Nigro G; Politano L
    Acta Myol; 2015 May; 34(1):9-13. PubMed ID: 26155064
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Central nervous system involvements in Duchenne/Becker muscular dystrophy].
    Kumagai T; Miura K; Ohki T; Matsumoto A; Miyazaki S; Nakamura M; Ochi N; Takahashi O
    No To Hattatsu; 2001 Nov; 33(6):480-6. PubMed ID: 11725514
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients.
    Werneck LC; Scola RH; Maegawa GH; Werneck MC
    Am J Med Genet; 2001 Oct; 103(2):115-20. PubMed ID: 11568916
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.
    Kemaladewi DU; Hoogaars WM; van Heiningen SH; Terlouw S; de Gorter DJ; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; ten Dijke P; 't Hoen PA
    BMC Med Genomics; 2011 Apr; 4():36. PubMed ID: 21507246
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy.
    Pandey GS; Kesari A; Mukherjee M; Mittal RD; Mittal B
    Neurol India; 2003 Sep; 51(3):367-9. PubMed ID: 14652441
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy.
    Verhaart IE; Heemskerk H; Karnaoukh TG; Kolfschoten IG; Vroon A; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
    Hum Gene Ther; 2012 Mar; 23(3):262-73. PubMed ID: 22017442
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
    Young CS; Mokhonova E; Quinonez M; Pyle AD; Spencer MJ
    J Neuromuscul Dis; 2017; 4(2):139-145. PubMed ID: 28505980
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients.
    Lee T; Takeshima Y; Kusunoki N; Awano H; Yagi M; Matsuo M; Iijima K
    J Hum Genet; 2014 Jan; 59(1):46-50. PubMed ID: 24225992
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Correlation between genotypes and phenotypes in pseudohypertrophic muscular dystrophy].
    Feng SW; Liang YY; Cao JQ; Song XM; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):653-7. PubMed ID: 23225043
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis.
    Salari N; Fatahi B; Valipour E; Kazeminia M; Fatahian R; Kiaei A; Shohaimi S; Mohammadi M
    J Orthop Surg Res; 2022 Feb; 17(1):96. PubMed ID: 35168641
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
    Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pathological evaluation of rats carrying in-frame mutations in the dystrophin gene: a new model of Becker muscular dystrophy.
    Teramoto N; Sugihara H; Yamanouchi K; Nakamura K; Kimura K; Okano T; Shiga T; Shirakawa T; Matsuo M; Nagata T; Daimon M; Matsuwaki T; Nishihara M
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32859695
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Duchenne muscular dystrophy: perspectives of treatment].
    Palmieri B; Sblendorio V
    Recenti Prog Med; 2006 Sep; 97(9):448-58. PubMed ID: 17017294
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions.
    Takeshita E; Minami N; Minami K; Suzuki M; Awashima T; Ishiyama A; Komaki H; Nishino I; Sasaki M
    Neuromuscul Disord; 2017 Jun; 27(6):569-573. PubMed ID: 28434908
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.
    Kunkel LM; Bachrach E; Bennett RR; Guyon J; Steffen L
    J Hum Genet; 2006; 51(5):397-406. PubMed ID: 16583129
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Splicing intervention for Duchenne muscular dystrophy.
    McClorey G; Fletcher S; Wilton S
    Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Duchenne muscular dystrophy gene and cancer.
    Jones L; Naidoo M; Machado LR; Anthony K
    Cell Oncol (Dordr); 2021 Feb; 44(1):19-32. PubMed ID: 33188621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.